Birtamimab

• Description :

  Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis[1].

• Product Name Alternative :

  NEOD001

• UNSPSC :

  12352203

• Target :

  Amyloid-β

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Neuronal Signaling

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/birtamimab.html

• Purity :

  99.93

• Solubility :

  H2O

• Smiles :

  [Birtamimab]

• Molecular Weight :

  (146.44 kDa)

• References & Citations :

  [1]AGertz M, et, al. Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design. Journal home page for Blood. Volume 138, Supplement 1, 23 November 2021, Page 2754.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 3

• CAS Number :

  [1608108-91-3]